Verdaguer J, Yoon J W, Anderson B, Averill N, Utsugi T, Park B J, Santamaria P
Department of Microbiology and Infectious Diseases, Faculty of Medicine, University of Calgary, Alberta, Canada.
J Immunol. 1996 Nov 15;157(10):4726-35.
The role of target cell autoantigens and their repertoire vs those of foreign Ags, superantigens, or non-Ag-specific stimuli in the activation and recruitment of effector T cells in most spontaneous models of autoimmune diseases remains elusive. Here we report on the use of single TCR-beta transgenic mice to study the mechanisms that drive the accumulation of pathogenic T cells in the pancreatic islets of nonobese diabetic (NOD) mice, a model for insulin-dependent diabetes mellitus. Expression of the V(beta)8.1+ TCR-beta rearrangement of a diabetogenic H-2Kd-restricted beta cell cytotoxic CD8+ T cell (beta-CTL) clone in NOD mice caused a 10-fold increase in the peripheral precursor frequency of beta-CTL and a selective acceleration of the recruitment of CD8+ T cells to the pancreatic islets of prediabetic animals. This resulted in an earlier onset and a faster progression of beta cell depletion, and led to a dramatic acceleration of the onset of diabetes. Most islet-derived beta-CTL from diabetic transgenic NOD mice expressed an endogenously-derived TCR-alpha sequence identical to that of the clonotype donating the TCR-beta transgene, and a TCR-alpha-CDR3 sequence homologous to those expressed by most islet-derived beta-CTL from nontransgenic NOD mice. TCR-beta transgene expression did not change the peripheral frequency of beta cell-specific CD4+ T cells, the rate at which these cells accumulated in the pancreatic islets, or the incidence of diabetes. Taken together, our data indicate that retention of CD8+ and CD4+ T cells in the pancreatic islets of NOD mice is driven by beta cell autoantigens, rather than by local superantigens or non-Ag-specific stimuli, and that beta-CTL are major effectors of beta cell damage in spontaneous insulin-dependent diabetes mellitus.
在大多数自身免疫性疾病的自发模型中,靶细胞自身抗原及其种类与外来抗原、超抗原或非抗原特异性刺激相比,在效应T细胞的激活和募集中所起的作用仍不清楚。在此,我们报告使用单TCR-β转基因小鼠来研究驱动致病性T细胞在非肥胖糖尿病(NOD)小鼠胰岛中积累的机制,NOD小鼠是胰岛素依赖型糖尿病的模型。在NOD小鼠中表达致糖尿病的H-2Kd限制性β细胞细胞毒性CD8+ T细胞(β-CTL)克隆的V(β)8.1+ TCR-β重排,导致β-CTL外周前体频率增加10倍,并选择性加速CD8+ T细胞募集到糖尿病前期动物的胰岛。这导致β细胞耗竭的发病更早且进展更快,并导致糖尿病发病急剧加速。来自糖尿病转基因NOD小鼠的大多数胰岛来源的β-CTL表达与捐赠TCR-β转基因的克隆型相同的内源性TCR-α序列,以及与来自非转基因NOD小鼠的大多数胰岛来源的β-CTL所表达的序列同源的TCR-α-CDR3序列。TCR-β转基因表达并未改变β细胞特异性CD4+ T细胞的外周频率、这些细胞在胰岛中积累的速率或糖尿病的发病率。综上所述,我们的数据表明,NOD小鼠胰岛中CD8+和CD4+ T细胞的滞留是由β细胞自身抗原驱动的,而非局部超抗原或非抗原特异性刺激,并且β-CTL是自发胰岛素依赖型糖尿病中β细胞损伤的主要效应细胞。